Skip to main content
Equibles

Troy Wilson

CEO

Kura Oncology, Inc. (KURA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Troy Wilson

Troy Wilson is recorded as CEO at Kura Oncology, Inc. (KURA). The proxy statement of Kura Oncology, Inc. reports total compensation of $4,735,016 for Troy Wilson in fiscal 2025, including a base salary of $700,000. Disclosed compensation is on record for 9 fiscal years. Troy Wilson has spoken on 23 earnings calls and 2 other investor events across 1 company, most recently for Kura Oncology, Inc. on September 16, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kura Oncology, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Kura Oncology, Inc. (KURA) $700,000 $4,735,016
2024 Kura Oncology, Inc. (KURA) $671,736 $6,239,098
2023 Kura Oncology, Inc. (KURA) $645,900 $5,251,407
2022 Kura Oncology, Inc. (KURA) $621,000 $5,304,349
2021 Kura Oncology, Inc. (KURA) $600,000 $8,743,784
2020 Kura Oncology, Inc. (KURA) $573,000 $4,192,116
2019 Kura Oncology, Inc. (KURA) $542,000 $3,236,217
2018 Kura Oncology, Inc. (KURA) $526,400 $4,745,838
2017 Kura Oncology, Inc. (KURA) $471,900 $1,721,112

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 13 earlier activities